Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Accenture
Chinese Patent Office
Deloitte
Farmers Insurance
Medtronic
Argus Health
Express Scripts
Fuji

Generated: January 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Serlopitant

« Back to Dashboard

US Patents for Serlopitant

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Serlopitant ➤ Sign Up Hydroisoindoline tachykinin receptor antagonists Merck & Co., Inc. (Rahway, NJ) ➤ Sign Up
Serlopitant ➤ Sign Up Hydroisoindoline tachykinin receptor antagonists Merck & Co., Inc. (Rahway, NJ) ➤ Sign Up
Serlopitant ➤ Sign Up Process for making hydroisoindoline tachykinin receptor antagonists Merck & Co, Inc. (Rahway, NJ) ➤ Sign Up
Serlopitant ➤ Sign Up Hydroisoindoline tachykinin receptor antagonists Merck Sharp & Dohme Corp. (Rahway, NJ) ➤ Sign Up
Serlopitant ➤ Sign Up Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence Merck Sharp & Dohme Corp. (Rahway, NJ) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Serlopitant

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Serlopitant Argentina 047439 2024-01-27 ➤ Sign Up
Serlopitant Austria 382034 2024-01-27 ➤ Sign Up
Serlopitant Australia 2005207934 2024-01-27 ➤ Sign Up
Serlopitant Brazil PI0507050 2024-01-27 ➤ Sign Up
Serlopitant Canada 2554550 2024-01-27 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKinsey
McKesson
Cipla
Cerilliant
QuintilesIMS
Cantor Fitzgerald
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: